Andy He

462 total citations
9 papers, 357 citations indexed

About

Andy He is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Genetics. According to data from OpenAlex, Andy He has authored 9 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Andy He's work include Iron Metabolism and Disorders (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Andy He is often cited by papers focused on Iron Metabolism and Disorders (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). Andy He collaborates with scholars based in United States. Andy He's co-authors include David B. Bregman, Todd A. Koch, Lawrence T. Goodnough, David L. Morris, Iftikhar Hussaın, Angelia Butcher, Sarina A. Piha‐Paul, Albiruni Ryan Abdul Razak, Chieh‐Chung Lin and Sammy Yuan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Journal of Cancer.

In The Last Decade

Andy He

7 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andy He United States 6 188 137 110 100 53 9 357
B. De Valk Netherlands 5 148 0.8× 95 0.7× 14 0.1× 89 0.9× 51 1.0× 11 335
Ercan Müldür Austria 5 170 0.9× 90 0.7× 17 0.2× 70 0.7× 17 0.3× 13 276
Geetika Srivastava United States 9 107 0.6× 20 0.1× 47 0.4× 153 1.5× 108 2.0× 31 411
Shigenori Kanazawa Japan 11 132 0.7× 25 0.2× 35 0.3× 94 0.9× 67 1.3× 23 419
María Borrell Spain 9 130 0.7× 41 0.3× 34 0.3× 33 0.3× 43 0.8× 22 343
Jung Hye Choi South Korea 12 87 0.5× 34 0.2× 84 0.8× 68 0.7× 86 1.6× 41 398
Agnieszka Szymczyk Poland 9 94 0.5× 86 0.6× 15 0.1× 115 1.1× 26 0.5× 40 368
Y Beguin United States 8 454 2.4× 343 2.5× 27 0.2× 22 0.2× 24 0.5× 8 566
Sarah T.B.G. Loubele Netherlands 6 239 1.3× 66 0.5× 41 0.4× 10 0.1× 34 0.6× 8 361
S. Fargion Italy 7 253 1.3× 191 1.4× 40 0.4× 14 0.1× 19 0.4× 12 480

Countries citing papers authored by Andy He

Since Specialization
Citations

This map shows the geographic impact of Andy He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy He more than expected).

Fields of papers citing papers by Andy He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy He. The network helps show where Andy He may publish in the future.

Co-authorship network of co-authors of Andy He

This figure shows the co-authorship network connecting the top 25 collaborators of Andy He. A scholar is included among the top collaborators of Andy He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy He. Andy He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
4.
Bestvina, Christine M., Laura Morrison, Bruno Émond, et al.. (2023). Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction (PCR) versus next-generation sequencing (NGS) testing strategies in metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 41(16_suppl). 6638–6638. 5 indexed citations
5.
Bang, Yung‐Jue, Toshio Doi, Filippo de Braud, et al.. (2015). 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028. European Journal of Cancer. 51. S112–S112. 112 indexed citations
6.
Malone, Margaret, Charles F. Barish, Andy He, & David B. Bregman. (2013). Comparative Review of the Safety and Efficacy of Ferric Carboxymaltose Versus Standard Medical Care for the Treatment of Iron Deficiency Anemia in Bariatric and Gastric Surgery Patients. Obesity Surgery. 23(9). 1413–1420. 27 indexed citations
8.
Goodnough, Lawrence T., David L. Morris, Todd A. Koch, Andy He, & David B. Bregman. (2012). Hepcidin Levels Predict Non-Responsiveness to Oral Iron Therapy in Patients with Iron Deficiency Anemia. Blood. 120(21). 484–484. 8 indexed citations
9.
Bregman, David B., David L. Morris, Todd A. Koch, Andy He, & Lawrence T. Goodnough. (2012). Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. American Journal of Hematology. 88(2). 97–101. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026